AI Engines For more Details: Perplexityβ Kagi Labsβ Youβ
Antiprotozoal Activity: Diclazuril is a member of the triazine class of antiprotozoal drugs, which exert their therapeutic effects by interfering with the metabolism and reproduction of protozoa such as Eimeria species. Diclazuril targets the intracellular stages of the coccidian parasites, preventing their development and replication within host cells.
Treatment of Coccidiosis: Diclazuril is highly effective in the treatment of coccidial infections in animals, including poultry (chickens, turkeys), cattle, sheep, goats, pigs, and other species. It helps reduce the severity of clinical signs associated with coccidiosis, such as diarrhea, dehydration, lethargy, and poor growth or weight gain, leading to improved health and productivity in affected animals.
Prevention of Coccidiosis: In addition to its therapeutic use, diclazuril is also used for the prevention of coccidial infections in animals raised in intensive farming systems, such as commercial poultry production. Prophylactic treatment with diclazuril can help reduce the risk of coccidiosis outbreaks and minimize economic losses associated with decreased feed efficiency, poor growth rates, and increased mortality in infected animals.
Broad-Spectrum Activity: Diclazuril exhibits broad-spectrum activity against various species and strains of Eimeria parasites that commonly infect domestic animals. It is effective against both sensitive and resistant strains of coccidia, making it a valuable tool for controlling coccidial infections in livestock and poultry populations.
Ease of Administration: Diclazuril is typically administered orally to animals, either in the form of medicated feed, drinking water, or oral suspensions. It is well-absorbed from the gastrointestinal tract and rapidly distributed throughout the body, reaching therapeutic concentrations in target tissues where coccidial parasites reside.
Safety and Tolerability: Diclazuril is generally safe and well-tolerated in animals when administered at recommended dosages. Adverse effects are rare but may include mild gastrointestinal upset (e.g., vomiting, diarrhea) or allergic reactions in sensitive individuals. Proper dosing and administration practices should be followed to minimize the risk of adverse effects and ensure optimal therapeutic outcomes.
Regulatory Considerations: Diclazuril is approved for veterinary use in many countries worldwide and is available in various formulations and concentrations for use in different animal species and production systems. Veterinary oversight and prescription may be required for the use of diclazuril in some jurisdictions, particularly in commercial farming operations.
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive β X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. β Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA β Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. β Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. β Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]